Clinical decision support categories
| Category | Description |
|---|---|
| Therapeutic duplication | Therapeutic overlap with another new or active order; may be same drug, same drug class, or components of combination products |
| Single and cumulative dose limits | Specified dose that exceeds recommended dose ranges; will result in a cumulative dose that exceeds recommended ranges; can also include dose limits for each component of a combination product |
| Allergies and cross allergies | Allergy has been documented or allergy to other drug in same category exists |
| Contraindicated route of administration | Order specifying a route of administration that is not appropriate for the identified medication |
| Drug–drug and drug–food interactions | Results in known dangerous interaction when administered together with a different medication or results in an interaction in combination with a drug or food group |
| Contraindications/dose limits based on patient diagnosis | Contraindication based on patient diagnosis or diagnosis affects recommended dosing |
| Contraindications/dose limits based on patient age or weight | Contraindication based on age or weight |
| Contraindications/dose limits based laboratory studies | Contraindication based on laboratory studies or for which laboratory studies must be considered for dosing |
| Contraindications/dose limits based radiology studies | Contraindication for this patient based on interaction with contrast medium (in ordered radiology study) |
| Corollary | Intervention that requires an associated or secondary order to meet the standard of care (prompt to order drug levels during medication ordering) |
| Cost of care | Test that duplicates a service within a time frame in which there is typically minimal benefits from repeating the test |
| Nuisance | Order with such a slight or inconsequential interaction that clinicians typically ignore the advice/prompt |